Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China flag China · Delayed Price · Currency is CNY
9.47
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST

SHE:300534 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
2,8732,8762,6392,9942,6914,465
Market Cap Growth
-5.02%8.97%-11.85%11.27%-39.74%154.23%
Enterprise Value
2,8362,8952,5062,9422,6084,404
Last Close Price
9.479.488.679.788.7914.58
PE Ratio
65.3665.43107.8248.5769.37-
PS Ratio
3.243.242.532.773.3715.51
PB Ratio
3.683.683.574.213.056.09
P/TBV Ratio
4.594.594.455.373.576.81
P/FCF Ratio
--19.23-11.1288.04
P/OCF Ratio
--12.2831.0210.0687.32
EV/Sales Ratio
3.203.262.402.723.2615.30
EV/EBITDA Ratio
21.7122.4118.6326.3431.31332.41
EV/EBIT Ratio
32.4333.0926.1035.9646.31-
EV/FCF Ratio
-56.84-18.26-10.7886.84
Debt / Equity Ratio
0.170.170.160.20--
Debt / EBITDA Ratio
1.011.010.851.29--
Debt / FCF Ratio
--0.84---
Net Debt / Equity Ratio
-0.14-0.14-0.26-0.20-0.42-0.13
Net Debt / EBITDA Ratio
-0.84-0.84-1.45-1.29-4.43-7.48
Net Debt / FCF Ratio
2.182.18-1.424.84-1.53-1.95
Asset Turnover
0.630.630.750.810.750.34
Inventory Turnover
2.442.442.734.224.834.02
Quick Ratio
1.111.111.031.211.503.59
Current Ratio
1.431.431.321.481.794.52
Return on Equity (ROE)
8.60%8.60%6.90%10.52%6.02%-0.86%
Return on Assets (ROA)
3.85%3.85%4.31%3.85%3.29%-0.69%
Return on Invested Capital (ROIC)
10.20%11.58%8.50%11.54%7.22%-1.41%
Return on Capital Employed (ROCE)
9.30%9.30%10.60%9.10%6.20%-1.20%
Earnings Yield
1.53%1.53%0.93%2.06%1.44%-0.20%
FCF Yield
-1.74%-1.74%5.20%-1.00%9.00%1.14%
Dividend Yield
0.42%0.42%0.46%0.21%--
Payout Ratio
33.75%33.75%63.61%6.19%1.28%-
Buyback Yield / Dilution
-0.01%-0.01%0.03%-0.05%0.10%0.54%
Total Shareholder Return
0.42%0.42%0.49%0.16%0.10%0.54%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.